Clinical Trials in Arizona - Capstone TherapeuticsByAZBio
Published: 2015-05-16 20:15:29
Capstone Therapeutics Corp. is a biotechnology company committed to developing a pipeline of novel peptides and other molecules aimed at helping patients with under-served medical conditions. Previously, we were focused on the development and commercialization of two product platforms: AZX100 and Chrysalin (TP508). Presenter- Jock Holliman
Categories: Events & Education
Sign in or Create an account to comment!